huntersyndromefoundation.org
Hunter Syndrome (MPSII) « Hunter Syndrome Foundation
https://huntersyndromefoundation.org/what-is-hunter-syndrome-mpsii
A CURE IS WITHIN REACH! Research for a Cure. What is Gene Therapy? Hunter Syndrome (or Mucopolysaccharidosis/MPS II) is a rare condition affecting between 1 in 100,000 to 1 in 150,000 male births, although it is estimated that the grouping of MPS conditions collectively affect 1 in 25,000 births in the United States (MPS conditions include MPS I, II, III, IV, VI, VII and ML II and III). Unrelated children with Hunter Syndrome often look alike and have a distinctive coarseness in their facial features, in...
armagen.com
AGT-182 and AGT-181 and Clinical Trials | ArmaGen
http://armagen.com/our-pipeline/clinical-trials
Solving the Blood- Brain Barrier Dilemma. Ongoing Trial: AGT-182 Phase 1 Trial in Hunter Syndrome. The purpose of this Phase 1 clinical trial is to test the safety and determine a well-tolerated dose of the investigational treatment AGT-182 for male patients (age 18 years and older) with Hunter syndrome or mucopolysaccharidosis type II (MPS II). More information about the trial is available on www.breakingbarriershuntertrial.com. Or www.clinicaltrials.gov. Using the identifier number. ArmaGen is conducti...
SOCIAL ENGAGEMENT